Read more: What is retatrutide
The peptide stimulates hippocampal neurogenesis and synaptic plasticity
Additionally, the FDA recommends that these medications not be taken during pregnancy and be discontinued at least two months prior to pregnancy, because studies in rats, rabbits, and monkeys demonstrated that animals treated with these medications had higher rates of miscarriage, were born smaller, and were more likely to have birth defects
Clinical Efficacy: Evidence from Major Trials Weight Loss Outcomes in Non-Diabetic Patients The clinical efficacy of GLP-1 agonists for weight loss in non-diabetic patients has been demonstrated across multiple large-scale randomized controlled trials
Retatrutide may help make portion control easier, support long-term metabolic health, and promote sustainable weight loss under professional guidance
Clinical trials show average weight loss of 15 to 17 percent of body weight over 68 weeks